| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0019 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0023 | 1 |